Real-time enrollment status for this metastatic triple-negative breast cancer clinical trial
Current Status
Recruiting
Checked: July 13, 2026 at 3:02 PM UTC
| NCT Number | NCT06963905 |
| Recruiting Status | Recruiting |
| Condition | Metastatic Triple-negative Breast Cancer |
| Phase | Clinical Trial |
| Target Enrollment | 60 participants |
| Active Locations | 1 sites in the US |
| Sponsor | Yale University |
| Last Updated on CT.gov | May 22, 2026 (May 22, 2026) |
As of July 13, 2026: Clinical trial NCT06963905 is currently recruiting participants. This clinical trial study for metastatic triple-negative breast cancer is actively seeking new participants at 1 location across the United States. The study is sponsored by Yale University. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06963905 is actively recruiting participants as of July 13, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06963905 was last updated May 22, 2026 (May 22, 2026). HelloStudys verifies this status automatically.